首页> 外国专利> INTRAVENOUS NANOPARTICLES FOR TARGETING DRUG DELIVERY AND SUSTAINED DRUG RELEASE

INTRAVENOUS NANOPARTICLES FOR TARGETING DRUG DELIVERY AND SUSTAINED DRUG RELEASE

机译:靶向给药和维持药物释放的静脉注射纳米颗粒

摘要

Provided are poly(lactic-co-glycolic acid) (PLGA) and poly(lactic acid) (PLA)nanoparticles that encapsulate a low~ molecular weight and water-soluble drugand can deliver the drug to target legion sites where the particles graduallyrelease the drug over a prolonged period of time. The nanoparticles areprepared by allowing the low-molecular, water-soluble and non-peptide drug tointeract with a metal ion so as to make the drug hydrophobic, encapsulatingthe hydrophobicized drug into PLGA or PLA nanoparticles, and allowing asurfactant to be adsorbed onto the surface of the particles.
机译:提供了聚乳酸-乙醇酸共聚物(PLGA)和聚乳酸(PLA)包裹低分子量水溶性药物的纳米颗粒并可以将药物递送到目标颗粒逐渐扩散的军团位置长时间释放药物。纳米粒子是通过使低分子,水溶性和非肽类药物与金属离子相互作用从而使药物疏水,包囊将疏水化药物制成PLGA或PLA纳米颗粒,并允许表面活性剂被吸附到颗粒表面。

著录项

  • 公开/公告号CA2518223A1

    专利类型

  • 公开/公告日2004-10-07

    原文格式PDF

  • 申请/专利权人 LTT BIO-PHARMA CO. LTD.;

    申请/专利号CA20042518223

  • 发明设计人 ISHIHARA TSUTOMU;MIZUSHIMA YUTAKA;

    申请日2004-03-11

  • 分类号A61K9/51;

  • 国家 CA

  • 入库时间 2022-08-21 23:04:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号